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INTRODUCTION
Emergency contraception (EC) as a means to prevent
unwanted pregnancies in special situations such as
condom accidents, sexual abuse, and unprotected
intercourse occurring around mid cycle, when there is a
high probability of pregnancy. It is estimated that wider
use of EC would greatly reduce the number of unwanted
pregnancies and the number of abortions resulting from
them .
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The most widely used emergency contraception
(EP) methods in the world are the Yuzpe regimen
(combined estrogen-progestin contraceptive pills) and the
levonorgestrel (LNG) regimen (progestin only). The
Yuzpe regimen was developed in 1980 and later compared
to the LNG regimen in clinical trials. In the large
randomized trial to date, the LNG regimen has been
shown to be more effective and associated with fewer side
effects than Yuzpe regimen . The Yuzpe method of
emergency contraception involves taking two doses of
combined estrogen/progestin pills, with each dose
containing 100 of ethinyl estradiol and 500 of
evonorgestrel. The first dose is taken within 72h of
unprotected coitus and the other is taken 12h later. The
total regimen is therefore 200 of ethinyl estradiol and 1
mg of levonorgestrel . But levonorgestrel 0.75 mg is
marked as two pills taken within 72h of unprotected coitus
and the other is taken 12h later . The most frequent
women's complaint was nausea and vomiting . Vomiting
occurs in about 5.6% of women taking the LNG regimen
compared to about 18.8% for theYuzpe regimen.
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The management of vomiting shortly after taking EC is
not well defined . Ho and Kwan reported fewer side effects
and better efficacy with levonorgestrel compared to the
Yuzpe method .Several clinical studies have shown that
combined emergency contraception pills (ECP) can
inhibit or delay ovulation . Some studies have shown
histologic or biochemical alterations in the endometrium
after treatment with the regimen, leading to the suggestion
that EPCs may act by impairing endometrial receptivity to
implantation of a fertilized egg . Additional possible
mechanisms include dysfunctional ovulation; interference
with corpus luteum function; thickening of the cervical
mucus resulting in trapping of sperm; alterations in the
tubal transport of sperm, egg or embryo; and direct
inhibition of fertilization . No clinical data exist
regarding the last three of these possibilities. The aim of
this study was to compare the effectiveness between the
Yuzpe and levenorgestrel regimens of EC in order to
introduce safer and more effective method.
One hundred twenty four healthy women volunteered for
randomized comparative study measuring the
effectiveness of two EC regimens from September 2006 to
June 2007. The protocol was approved by the Shahid
Sadoughi University Ethics Board and written informed
choice was obtained from all participants. The comparison
was focused on two regimens of postcoital contraception
(PCC): the Yuzpe regimen and LNG. In the levenorgestrel
group and the Yuzpe regimen group, 62 women were
randomly allocated in each group. Randomisation was
performed by the randomisation schedules. Having only
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The purpose of this study was to compare the efficacy and tolerability of two emergency
contraception (EC) methods, levonorgestrel versus theYuzpe.
In a prospective, randomized, comparative study, we included 122 healthy volunteers who in the
observed cycle had had only one act of unprotected intercourse within 72h of treatment. They were randomly
allocated in levonorgestrol group (n=62) and Yuzpe (n=60). The levonorgestrel regimen consisted of two pills:
0.75 mg levonorgestrel, taken twice in the 12-h interval within 72h after unprotected intercourse. The Yuzpe
method included two HD contraceptive pills taken as another regimen. Data were collected by questionnaire at
first and 3 weeks later. The differences were compared with X &Fisher exact tests.
There were no significant differences between two groups in any of the observed parameters. The
levonorgestrel regimen was found superior to Yuzpe because it's more effectiveness (respectively 100% vs
91%, p=0.026) and fewer side effects.
The study showed more effectiveness and safety of the levonorgestrel regimen as emergency
contraception. Thus we recommend levonorgestrel as an alternative EC method instead of the Yuzpe regimen
in Iran or other developing countries in order to decrease unwanted pregnancy.
Yuzpe, Levonorgestrel, emergency contraception
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Complications Yuzpe Group
(n=60)
LNG Group
(n=62)
Pvalue
Nausea 68.3 6.5 0.000
Vomiting 25 0 0.000
Headache 21.7 0 0.000
Weakness 16.7 1.6 0.004
Hot flash 6.7 3.2 0.436
one act of unprotected intercourse within 72h of treatment
in the observed cycle was study inclusion criteria. Reasons
for exclusion included a history of irregular menstrual
cycles, contraindications to hormonal contraception
including imparted liver function, blood clotting
disorders, family or personal history of venous
thromboembolism or pulmonary embolism, intolerance to
oral contraceptives and not to return for follow up visit.
The levonorgestrel regimen consisted of two pills: 0.75
mg levonorgestrel taken twice in the 12h interval. The
Yuzpe regimen consisted of two tables of ethynylestradiol
100 and levonorgestrel 500 taken twice in the 12h
interval as well.
Finally, the medical history was taken and general
examination and a pregnancy test were performed. All
women were keeping a diary of the menstrual period and
side effects, coitus protection with condom after the PCC
in the same cycle and were asked to return for a follow-up
visit one week after the expected menstrual period. The
pregnancy was confirmed by a positive pregnancy test.
Data were collected by Questionnaires that the study team
completed them. The differences were compared with
X &Fisher exact tests.2
RESULTS
Demographic characteristics for the five subjects studied
on the Yuzpe regimen and LNG regimen are provided in
Table 1. There were no significant differences between the
groups in any of the observed parameters. Two women
were excluded from the study because they were lost to
follow-up. Pregnancy occurred in five patients (8.3%) in
the Yuzpe regimen, but no pregnancy occurred in the LNG
(p=0.026) . In the Yuzpe group 60% of women and in the
LNG group 62% of women reported normal and regular
menses in the treatment cycle. But menstruation time was
changed in 30% of women in the Yuzpe and 37% in the
LNG group (Table.1). None of the observed women
reported any change in the length or amount of bleeding.
There was no vomiting and necessity for substitute pill
intake in the levonorgestrel group. Nausea, vomiting,
headache and weakness were statistically less frequent.
Otherwise a higher frequency of these parameters was
observed in theYuzpe group (Table.2).
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Param eter Yuzpe
reg imen
(n=6 0)
m ea n (SD)
Lev onorg estrel
(n=62)m ean(SD
P value
a
Mean Age (years) 2 9.1(±7) 26.3(±6) 0.33
Gravid 3 .03(±2.2 ) 2.4(±2.1 ) 0.11 8
Par ity 2 .8(±2.23 ) 2.3(±2.1 3) 0.18
Menstruation time
with PCC
Normal cycle vs.
af ter treatment
Early menstruation
Late menstruation
3 6(60% )
1 4(23.3%)
5 (6.6% )
39(62 .09%)
18(29 .03%)
5(8.06 %)
0.94 5
Interval between
co itus and PCC(h)
7 .9(±8.0 1) 11.6(±13 .3) 0.06 5
Table 1: Demographics for Subjects Studied on The Yuzpe Regimen and Levonorgestrol Regimen.
Table 2: Incidence of Complaints after Postcoital Intake of Each Regimen (%).
Early mensturation is occurance of
mensturation earlier of normal periods
for the same woman.
Late Mensturation is occurance of
mensturation later than normal periods
for the same woman.
PCC:
SD:
a:
Post coital contraception;
Standard deviation;
If P was less than 0.05, there was significant differnce between two parametrvalue
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DISCUSSION
CONCLUSION
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We evaluated two regimens of PCC: levonorgestrel and
Yuzpe regimens in a prospective, randomized,
comparative study. Concerning baseline subjects, the
patients in both groups were similar. We observed that
pregnancy occurred in five patients (8.3%) in the Yuzpe
regimen, but no pregnancy occurred in the LNG
(p=0.026).Wilcox has calculated the probability of
conception to range from 10%, when intercourse occurs
five day before ovulation, to 33%, when it occurs on the
day of ovulation itself . Pretnar-Darovec et al showed that
no pregnancies occurred in their study of the WHO
multicenter trial. They are aware of the fact that this may
be due to the small number of observed cycles . Ho et al
compared the Yuzpe and levonorgestrel regimen and
found that the pregnancy rate was 3.5% in the Yuzpe
regimen compared to 2.9% in the LNG regimen . The best
evidence showed that the proportion of pregnancies
prevented(compared with the expected number without
treatment) is about 85% for the LNG regimen compared to
57% for the Yuzpe regimen . A meta analysis of eight
studies including the WHO study of 1998(Task Force
1998) concluded that when used within 72h of coitus, the
Yuzpe regimen prevents about 74% of expected
pregnancies . Our results may be due to a small number of
observed cycles.Pregnancy rate has been shown to be
inversely related to the time the pill was taken after
intercourse . In most cases enrolled in our study, the
interval between intercourse to take pill was less than
24h. Our study agrees with the conclusions drawn from
the entire WHO trial that the pill should be taken as soon as
possible after unprotected intercourse. There is concern
about decreased absorption and contraceptive
effectiveness subsequent to vomiting shortly after taking
EC .
Gynaecologists practice Bulletin on emergency oral
contraception showed that “there is no evidence on which
to base a recommendation for repeating the dose if emesis
occurs. But it seems reasonable to infer that if
gastrointestinal symptoms are estrogen mediated
secondary to an effect on the central nervous system,
absorption of the dose should have occurred by the time of
emesis” . There was no significant changes in the
menstrual cycles after these regimens. The side effects of
both regimens were assessed. The differences in side
effects between two groups were statistically significant
and similar to those of other studies . Yuzpe reported that
nausea occurred in up to 50% of cases .The women in our
Yuzpe group experienced nausea in 68.3% and vomiting
in 25%.These side effects were less frequently after
levenorgestrel regimen.
The study showed more effectiveness and safety of the
levonorgestrel regimen as emergency contraception. We
recommend the use of levonorgestrel as an alternative EC
method instead of the Yuzpe regimen as soon as possible
in Iran or other developing countries in order to reduce the
prevalence of unwanted pregnancy.
The authors would like to thank the study counsellors
ProfessorAbass Aflatonian, Dr Ali Babaei and the women
who participated in the trial.
9
4
5
10
11
10
12,13
14
4
15
REFERENCES
1. Croxatto HB, Fuentalba B, Brache V
2. Kives S, Hahn PM, White E, Stanczyk FZ, Reid
RL.
3. Trussell J, Ellertson C, Dorflinger L.
4. Pretnar-Darovec A, Pinter B, Vrtacnik-Bokal E.
5. Ho PC, Kwan MSW.
6. Swahn M.L, Westlund P, Johannisson E,
Bygdeman M.
7. Raymond EG, Lovely LP, Chen-Mok M, Seppala
M, Kurman R J, Lessey BA.
8. Croxatto HB, Devoto L, Durand M.
9. Wilcox AJ, Weinberg CR, Baird DD.
10.
11. Croxatto HB, Devoto L, Durand M, et al.
12.
13. Von Hertzen H, Van Look PF.
14.
15. Yuzpe AA, Lance WJ.
. Effects of
the Yuzpe regimen, given during the follicular phase,
on ovarian function. Contraception 2002; 65: 121-
128.
Bioavailability of the Yuzpe and levonorgestrel
regimens of emergency contraception: vaginal vs.
Oral administration. Contraception, 2005; 71(3):
197-201.
Effectiveness
of the Yuzpe regimen of emergency contraception by
cycle day of intercourse: implications for mechanism
of action. Contraception, 2003; 67(3): 167-71.
Emergency contraception: levonorgestrel versus the
Yuzpe regimen. Book of Contraceptive: choices and
realities, 2000; chapter 29: 128-31.
A prospective randomised
comparison of levonorgestrel with the Yuzpe
regimen in postcoital contraception. Hum Reprod
1993; 3: 389-92.
Effect of postcoital contraceptive
methods on the endometrium and the menstural
cycle. Acta Obstet Gynecol Scand, 1996; 75: 738-
744.
Effect of the Yuzpe
regimen of emergency contraception on markers of
endometrial receptivity. Hum Reprod 2000; 15:
2351-2355.
Mechanism of
action of hormonal preparation used for emergency
contraception: a review of the literature.
Contraception, 2001;63: 111-121.
Timing of
sexual intercourse in relation to ovulation: effects on
the probability of conception, survival of the
pregnancy, and sex of the baby. N Engl J Med, 1995;
333:1517-21.
Task Force on Postovulatory Methods of Fertility
Regulation. Randomized controlled trial of
levonorgestrel versus the Yuzpe regimen of
combined oral contraceptives for emergency
contraception. Lancet, 1998; 352:428-33.
Mechanism of action of hormonal preparations used
for emergency contraception: a review of the
literature. Contraception, 2001; 63: 111-121.
Anonymous, Nausea, Vomiting and the efficacy of
post-coital contraception. Practitioner,1989;
233:1050.
Research on new
methods of emergency contraception. Fam Plann
Perspect 1996; 28: 52-7.
Emergency oral contraception, ACOG pract, 2001;
Bull: 25.
Ethinyl estradiol and dl-
norgestrel as a postcoital contraceptive. Fertil Stril
1977; 28: 932-6.
